Erdosteine for reducing inflammation in COPD
Part of Lungs & breathing clinical trials.
This trial tests whether a medication called erdosteine can help reduce inflammation in people with stable COPD. It may help improve breathing and reduce flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years or older
- You have had a COPD diagnosis for at least 1 year
- Your COPD is stable, meaning no flare-ups or respiratory infections in the last 3 months
- Your lung function test shows moderate to severe obstruction (FEV1 between 30% and 80% of predicted)
- You have not been hospitalized for any reason in the last 3 months
- You are currently taking inhaled COPD medications (LAMA/LABA or LAMA/LABA/ICS) and have not changed the dose in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach to reduce flare-ups (sudden worsening of symptoms) in people with COPD. If you've had frequent flare-ups, this trial may help you manage your condition better.
This study looks at how inflammation and oxidative stress affect COPD. It tests whether a pulmonary rehabilitation program helps reduce these factors in people with stable COPD who are former smokers.
This trial tests a structured review process to help people with COPD who have needed multiple steroid pills in the past year. It aims to improve care and prevent future harm from the condition.
This trial tests a new medicine called PF-07275315 for people with moderate to severe COPD. It aims to see if it can help reduce flare-ups (sudden worsening of symptoms) when added to your usual treatment.
This trial tests whether adding a medicine called doxofylline to your usual COPD inhalers can improve your lung function. It is for people with stable COPD who are already taking two types of long-acting inhalers.
This study tests whether a structured care program for COPD can lower how often your symptoms flare up. It may help by improving everyday management and preventing future worsening.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.